Multiple Viral Ligands Naturally Presented by Different Class I Molecules in Transporter Antigen Processing-Deficient Vaccinia Virus-Infected Cells

Supplemental material

Files in this Data Supplement:

• Supplemental file 1 - Supplemental figure legends
  PDF file, 30K.
• Supplemental file 2 - Fig. S1 (VACV infection in the presence of different protease inhibitors.)
  PDF file, 74K.
• Supplemental file 3 - Fig. S2 (Identification of three HLA-A*0201 ligands in infected cell extracts by mass spectrometry.)
  PDF file, 59K.
• Supplemental file 4 - Fig. S3 (Identification of three HLA-B27 ligands in infected cell extracts by mass spectrometry.)
  PDF file, 71K.
• Supplemental file 5 - Fig. S4 (Identification of three HLA ligands in infected cell extracts by mass spectrometry (I).)
  PDF file, 70K.
• Supplemental file 6 - Fig. S5 (Identification of three HLA ligands in infected cell extracts by mass spectrometry (II).)
  PDF file, 70K.
• Supplemental file 7 - Table S1 (Characteristics of HLA ligand-containing VACV proteins.)
  PDF file, 24K.